Clinical Trials Browser

Not yet recruiting × NETWORK × revumenib × Clear all

NCT07563010 2026-05-04

Menin-Inhibitor Targeted Maintenance in AML

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute